These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2940960

  • 21. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 22. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
    Ryoo HL, Pierrotti D, Joyce JN.
    Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Biochemical analysis of caudate nucleus biopsy samples from parkinsonian patients.
    Goldstein M, Lieberman AN, Helmer E, Koslow M, Ransohoff J, Elsworth JD, Roth RH, Deutch AY.
    Ann Neurol; 1988 Nov; 24(5):685-8. PubMed ID: 2904793
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia.
    Pearce RK, Seeman P, Jellinger K, Tourtellotte WW.
    Eur Neurol; 1990 Nov; 30 Suppl 1():9-14. PubMed ID: 2138080
    [Abstract] [Full Text] [Related]

  • 30. Dopamine receptors in the Parkinsonian brain.
    Rinne UK, Lönnberg P, Koskinen V.
    J Neural Transm; 1981 Nov; 51(1-2):97-106. PubMed ID: 6114985
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging.
    Morgan DG, Marcusson JO, Nyberg P, Wester P, Winblad B, Gordon MN, Finch CE.
    Neurobiol Aging; 1987 Nov; 8(3):195-201. PubMed ID: 3600950
    [Abstract] [Full Text] [Related]

  • 33. Dopamine receptors and transporters in Parkinson's disease and schizophrenia.
    Seeman P, Niznik HB.
    FASEB J; 1990 Jul; 4(10):2737-44. PubMed ID: 2197154
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Presynaptic parkinsonism in olivopontocerebellar atrophy: clinical, pathological, and neurochemical evidence.
    Pascual J, Pazos A, del Olmo E, Figols J, Leno C, Berciano J.
    Ann Neurol; 1991 Sep; 30(3):425-8. PubMed ID: 1952831
    [Abstract] [Full Text] [Related]

  • 36. The short-duration response to apomorphine: implications for the mechanism of dopaminergic effects in parkinsonism.
    Gancher ST, Woodward WR, Gliessman P, Boucher B, Nutt JG.
    Ann Neurol; 1990 Jun; 27(6):660-5. PubMed ID: 2360803
    [Abstract] [Full Text] [Related]

  • 37. Regional analysis of D2 dopamine receptors in Parkinson's disease using SPECT and iodine-123-iodobenzamide.
    Nadeau SE, Couch MW, Devane CL, Shukla SS.
    J Nucl Med; 1995 Mar; 36(3):384-93. PubMed ID: 7884499
    [Abstract] [Full Text] [Related]

  • 38. Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
    Seeman P, Ulpian C, Bergeron C, Riederer P, Jellinger K, Gabriel E, Reynolds GP, Tourtellotte WW.
    Science; 1984 Aug 17; 225(4663):728-31. PubMed ID: 6147018
    [Abstract] [Full Text] [Related]

  • 39. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
    Mita T, Hanada S, Nishino N, Kuno T, Nakai H, Yamadori T, Mizoi Y, Tanaka C.
    Biol Psychiatry; 1986 Dec 17; 21(14):1407-14. PubMed ID: 2947636
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.